Sign in / Join Now
ETFs & Funds
- Still undervalued, but the market is finally catching up. Look out for ASCO in May for potentially groundbreaking news on DC-Direct.
Add a reply...
Latest StockTalks »
people get NWBO breaking news and analysis by email alert.
Get email alerts on NWBO »
Northwest Biotherapeutics, Inc.
Get latest price
From other sites
NW Bio Provides Update About Phase 3 Trial Of DCVax®-L For Newly Diagnosed Glioblastoma Multiforme Brain Cancer
at TheStreet (Thu, 2:04PM)
NW Bio Announces Decision To Voluntarily Withdraw From Nasdaq Listing And Begin Trading On OTC Market
at TheStreet (Wed, 8:00PM)
NW Bio Announces Phase II Clinical Trial Program Combining DCVax®-L And Pembrolizumab (Keytruda®) For Colorectal Cancer
at TheStreet (Nov 17, 2016)
NW BIO Announces Registered Direct Offering
at TheStreet (Oct 21, 2016)
NW Bio Presents Further DCVax®-Direct Phase I Trial Information On Individual Patient Survival At NY Cancer Immunotherapy Conference
at TheStreet (Sep 29, 2016)